跳至主要内容
临床试验/TCTR20210514006
TCTR20210514006招募中不适用

Incidence of genetic abnormalities in patients with primary hypereosinophilia

Siriraj Hospital Mahidol University0 个研究点目标入组 151 人开始时间: 2021年5月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
151

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1) The patients diagnosed with primary hypereosinophilia type white blood cells greater than 1,500 per microliter for a period of more than 1 month
  • 2) 18 years of age and over
  • 3) Patients who received the gene test The specific targeted fusion gene panel with hypereosinophilia
  • 4) was welcomed to join the program by signing.

排除标准

  • 1.The patient was detected from a bacterial infection by antibody detection Research projects in which patients are examined. Incidence of nasopharyngeal carcinoma in patients primary hypereosinophilias 686 / 2563 (IRB2)
  • 2.Patients with allergic history
  • 3.Asthma patients
  • 4. Patients with immune diseases
  • 5 Patients diagnosed with various cancers are not in peacetime.
  • 6. History of steroid use in patients with herbs or drugs in the past three months
  • 7. The patients had a history of adverse events leading to leukocyte disease, hypertension, and xa0;
  • Penicillin, cephalosporin, GM-CSF, NSAID, ranitidine, isopropanol, isopropanol, alanine, amazillin sulfate, chlorazine, chlorazine Cyclospora

研究者

发起方
Siriraj Hospital Mahidol University

相似试验